Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.16 USD | -4.53% | -5.08% | -28.61% |
Evolution of the average Target Price on Pharming Group N.V.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Pharming Group N.V.
RBC Capital Markets | |
Oppenheimer |
EPS Revisions
- Stock Market
- Equities
- PHARM Stock
- PHAR Stock
- Consensus Pharming Group N.V.